In what started off as a mixed day for biotechs, a number of announcements made throughout the day ensured a number of biotechs had a reasonable Tuesday.
SRX started the day on a high after informing the market that it will be added to the S&P ASX200 on the 24 of December; a nice Christmas gift for holders.
ALT announced that they had signed a letter of intent with a Brazilian burette distributor. The company expects the Analytica AutoStart Burette to be rolled out initially across Brazil and then to the rest of South America. Although not yet a commercial agreement, this is a massive step for a small biotech.
In other news, ACG has received a $696,786.25 refund from the Australian Tax Office under the R&D tax incentive program. It is expected these funds will be paid into AtCor’s bank account this month or early January.
Winners and losers PGL put on 11.11% during yesterday's trade while ACG managed to add 7.69% on the back of news of a tax refund. SRX finished the day up 4.86% despite being up much more during trade while AHZ and PRR both put on more than 4%. BDM suffered the largest fall on Tuesday, down 11.77% on low volume. BCT, PAB and PBT were all down 4.65% while all other biotechs in the red were down less than 4%.
On the back of yesterday's feedback, today I will take tips for the the Top 3 Biotech stocks for 2013. The stock price percentage change will be measured at the closing price of December 24 to the same time in 2013. To enter, please reply to this post with the 3 stocks you wish to select.
